Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03578315
Other study ID # 201612113DINC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2018
Est. completion date July 31, 2020

Study information

Verified date January 2020
Source National Taiwan University Hospital
Contact Yi-Hua Liao
Phone 0972651558
Email yihualiao@ntu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators demonstrated that in vivo THG microscopy can differentiate Solar lentigos (SL), Nevus zygomaticus(NZ) and normal skin based on the optical nature of melanin. This THG-based procedure provides a valuable tool for noninvasive determination of third-order nonlinear susceptibility of melanin within the skin. It can also provide real-time histopathology information for treatment follow-up, without performing an invasive skin biopsy.


Description:

A nonrandomized, controlled, split-face comparative study was conducted to compare the efficacy and safety between quality-switched ruby laser (QSRL) and 532-nm picosecond Nd:YAG laser (532-PSNYL for SL, 1064-PSNYL for NZ) in the treatment of solar lentigo clinically and histologically by harmonic generation microscopy (HGM). After baseline photography and in vivo harmonic generation microscopy (HGM) imaging, QSRL and 532-PSNYL or 1064-PSNYL therapy for solar lentigos and nevus zygomaticus on the left and right side of the face, respectively, were performed for each subject. The subjects underwent follow-up assessment at weeks 3 and 6.

Statistical analysis: All data gathered went through decoding and were analyzed by blinded evaluators using SPSS software (version 20.0; IBM, Armonk, NY). All tests were two-sided. A P value of < .05 was considered to be statistically significant.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date July 31, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 85 Years
Eligibility 1. Main inclusion criteria:

1. Subjects are aged 20 to 85 years at Screening, and can be either sex.

2. Subjects are Fitzpatrick skin type III or IV.

3. Subjects must have been diagnosed to have solar lentigos or nevus zygomaticus, which are larger than 4 mm in diameter on both sides of the face.

2. Main exclusion criteria:

1. Subjects have previous treatments on the solar lentigos or nevus zygomaticus.

2. Subjects have a history of adverse reaction to laser treatments, including allergy to topical anesthesia application.

3. Subjects have a history of chronic inflammatory disorder such as atopic dermatitis on the face.

4. Subjects are pregnant or breast feeding.

5. Subjects have frequent sun exposure (=4 hours per day).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
HGM
To Study the Efficacy and safety of QSRL and PSNYL in the Treatment of target: A nonrandomized, controlled, split-face comparative study

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary 25 participants with Solar Lentigo and 25 participants with Nevus zygomaticus as assessed by clinical photographs The primary endpoint is the improvement of target at week 6 scored with a 7-grade. physician global assessment 6 months
Secondary 25 participants with Solar Lentigo and 25 participants with Nevus zygomaticus as assessed by Harmonic Generation Microscopy. The HGM system will be combined to provide the noninvasive microscopic images in SL and NZ sites during each follow-up for pathological diagnosis 1-2 hours per case
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05886010 - Performance and Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in th Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) on the Face and Hands of Asian Ethnicity Skins N/A
Completed NCT03225729 - Assessment of CRYOBEAUTY MAINS ET DECOLLETE Versus Liquid Nitrogen Cryotherapy, in the Treatment of Solar Lentigines N/A
Active, not recruiting NCT06288607 - Safety and Efficacy of High Intensity Focused Ultrasound in Solar Lentigo: A Self-controlled Study
Recruiting NCT06363240 - Evaluation of Broadband Light Treatment for Solar Lentigines N/A
Completed NCT03157427 - Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers. N/A
Not yet recruiting NCT05883657 - Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) N/A
Completed NCT05322668 - Tolerance of Cyto-selective Difluoroethane-based Cryotherapy N/A
Completed NCT05203263 - Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept N/A
Not yet recruiting NCT06361251 - Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face N/A
Not yet recruiting NCT06305897 - Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face N/A
Completed NCT05625815 - Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots. N/A